173 related articles for article (PubMed ID: 32786549)
1. Inhibition of Thioredoxin Reductase by Triosmium Carbonyl Clusters.
Koh WX; Coppo L; Holmgren A; Kong JW; Leong WK
Chem Res Toxicol; 2020 Sep; 33(9):2441-2445. PubMed ID: 32786549
[TBL] [Abstract][Full Text] [Related]
2. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl
Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG
Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260
[TBL] [Abstract][Full Text] [Related]
3. Cobaltoceniumethynyl gold(I) as an unusual heterodinuclear bioorganometallic fragment to study the biological properties of alkynyl gold complexes.
Vanicek S; Kopacka H; Wurst K; Vergeiner S; Kankowski S; Schur J; Bildstein B; Ott I
Dalton Trans; 2016 Jan; 45(4):1345-8. PubMed ID: 26732365
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
5. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
Chen JC; Zhang Y; Jie XM; She J; Dongye GZ; Zhong Y; Deng YY; Wang J; Guo BY; Chen LM
J Inorg Biochem; 2019 Apr; 193():112-123. PubMed ID: 30711557
[TBL] [Abstract][Full Text] [Related]
7. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
8. Cationic and Neutral N-Heterocyclic Carbene Gold(I) Complexes: Cytotoxicity, NCI-60 Screening, Cellular Uptake, Inhibition of Mammalian Thioredoxin Reductase, and Reactive Oxygen Species Formation.
Zhang C; Hemmert C; Gornitzka H; Cuvillier O; Zhang M; Sun RW
ChemMedChem; 2018 Jun; 13(12):1218-1229. PubMed ID: 29603648
[TBL] [Abstract][Full Text] [Related]
9. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
11. Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors.
Cheng Y; Qi Y
Anticancer Agents Med Chem; 2017; 17(8):1046-1069. PubMed ID: 28270080
[TBL] [Abstract][Full Text] [Related]
12. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
13. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
Yan J; Xu Y; Jin X; Zhang Q; Ouyang F; Han L; Zhan M; Li X; Liang B; Huang X
Eur J Med Chem; 2022 Jan; 227():113897. PubMed ID: 34649064
[TBL] [Abstract][Full Text] [Related]
14. Gold(I) NHC Complexes: Antiproliferative Activity, Cellular Uptake, Inhibition of Mammalian and Bacterial Thioredoxin Reductases, and Gram-Positive Directed Antibacterial Effects.
Schmidt C; Karge B; Misgeld R; Prokop A; Franke R; Brönstrup M; Ott I
Chemistry; 2017 Feb; 23(8):1869-1880. PubMed ID: 27865002
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors.
Qiu X; Liu Z; Shao WY; Liu X; Jing DP; Yu YJ; An LK; Huang SL; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Sep; 16(17):8035-41. PubMed ID: 18678491
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity.
Chew EH; Lu J; Bradshaw TD; Holmgren A
FASEB J; 2008 Jun; 22(6):2072-83. PubMed ID: 18180330
[TBL] [Abstract][Full Text] [Related]
17. Novel Phenylmethylenecyclohexenone Derivatives as Potent TrxR Inhibitors Display High Antiproliferative Activity and Induce ROS, Apoptosis, and DNA Damage.
Wang X; Qian J; Zhu P; Hua R; Liu J; Hang J; Meng C; Shan W; Miao J; Ling Y
ChemMedChem; 2021 Feb; 16(4):702-712. PubMed ID: 33085980
[TBL] [Abstract][Full Text] [Related]
18. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
[TBL] [Abstract][Full Text] [Related]
19. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]